Vaccine Manufacturing

28 September 2026

Africa CDC's Continental Immunisation Strategy 2026-2030 aims to close vaccine coverage gaps, fix financing and boost local manufacturing.

15 May 2026

Discover the benefits of the Africa Vaccine Procurement Framework for vaccine manufacturing and demand aggregation in Africa.

13 May 2026

Biovac's expansion funding in Africa hits $128m after a $20m French finance commitment, with the full $180m target due by the end of May.

21 April 2026

Biovac secures major funding for African vaccine manufacturing. The expansion is supported with funds from the EIB and IFC.

14 April 2026

The One Health Summit showcased important discussions on health sovereignty and climate-related health challenges worldwide.

16 March 2026

Cape Town biotech firm Afrigen’s business rescue begins as the WHO-backed mRNA hub seeks new investment to secure vaccine manufacturing.

19 August 2025

Regulatory delays are hindering Africa's R1.25-trillion pharmaceutical manufacturing goals and access to markets.

16 July 2025

Explore the future of local medicine manufacturing as Sahpra fast-tracks evaluation to secure South Africa's national supply.

29 June 2025

Biovac secures a deal with Biological E to produce a pneumonia vaccine in Africa, promoting vaccine independence continent-wide.

Search the archive

Browse by month